Virtually Painless Laser Hair Removal – Soprano
With our state-of-the-art laser system, the Soprano Lite, which is a revolutionary 810 nm diode laser hair removal solution with ICE tip technology, we offer the most effective and comfortable “Virtually Painless Laser Hair Removal”.
We use the very best laser machine on the market. What does that mean to you? The most effective treatments every session, you will be hair free in less sessions than with other generic laser hair removal machines. The big kicker with these machines is that you will find your session to be virtually painless, unlike IPL which is rather painful. Our machine, the Soprano Lite with an Ice tip technology is also safe for all ages and skin types 1-6 on the Fitzpatrick chart which is almost all skin types.
Soprano uses pulses of infrared diode laser energy to gradually heat the hair follicles in the subdermal layer of skin until eventually, the hair can no longer grow. With the combination of IN-Motion technology and a patented Dual Chill treatment tip, the surface of your skin remains cool throughout the treatment.
SAVE 15% OFF OUR PACKAGE DEALS – 3 OR 6 SESSIONS
LASER HAIR REMOVAL PRICING
Full Back & Chest
Hands & Fingers
The Soprano Lite is a revolutionary 810 nm diode laser hair removal solution.
The world’s best-selling laser hair removal technology is installed in over
3,500 clinics worldwide.
- Gold Standard 810 Diode
- 8 years of clinically proven effectiveness
- FDA cleared for skin types I-VI and tanned skin
- Fast, cool treatment for the patient
*Permanent reduction in hair regrowth defined as a long term, stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regime.
The Gold Standard 810 diode wavelength is backed by years of clinical proven effectiveness. Combined with Super Hair Removal (SHR™), you can offer virtually painless hair removal without sacrificing efficacy or patient comfort.
The Soprano Lite’s patented SHR technology works by gradually heating the dermis to a temperature that effectively damages the hair follicle. This means that hair follicles do not have to be exposed to a single pulse of high energy, which can injure the skin and cause the patient pain and suffering.
At the same time, the Soprano Lite protects the surrounding tissue.
The combination of 810 diode, SHR and cooling give you the ability to offer a superior laser hair removal experience and achieve greater results.
What Physicians are Saying About SHR
SHR™ technology has been the subject of numerous white papers, peer reviewed articles and other professional studies. In studies comparing SHR to other laser hair removal technologies, SHR was found to be effective in dark skinned patients.
“The use of SHR in patients with dark skin types may substantially reduce pain or discomfort and minimize severity of blistering, scabbing, crusting and hyper/hyperpigmentation. In addition, little to no prolonged epidermal effects such as redness and inflammation of the epidermis, and no downtime before (no topical anesthesia) or after treatment makes the SHR a comfortable treatment.”
White Paper by Dr. Tania Meneghel,
Renaissance Clinic, Sao Paulo, Brazil
“SHR is virtually not painful due to the excellent isolation of the thermal effects in the tissue surrounding the follicle. The use of low fluences and relatively short pulses with high repetition frequency, together with a skin surface air cooling, results in a well-tolerated treatment by patients, particularly those with dark photo types.”
White Paper by Dr. Rerfando Uridales,
Miramar Instituto Medico, Malaga, Spain
“Treatments with SHR are virtually painless with the diode laser producing long-term hair reduction in excess of 90%… Rapid pulse, constant motion with the low fluence diode laser represents an advance in safety, efficiency and tolerability of laser hair removal treatment.”
Peer review article by Dr. Martin Braun,
Vancouver Laser and Skin, Vancouver, Canada
“Treatment with SHR is considerable less painfull than with the Lightsheer.”
Long-term clinical study by Dr. Christopher Zachary,
Department Chair, University of California, Irvine, USA